Diagnostic serum vitamin D level is not a reliable prognostic factor for resectable breast cancer

被引：5

作者：

Kaya, Dilsa Mizrak ^{[1
,2
]}

Orturk, Bengi ^{[1
]}

Kubilay, Pinar ^{[1
]}

Onur, Handan ^{[1
]}

Utkan, Gungor ^{[1
]}

Senler, Filiz Cay ^{[1
]}

Alkan, Ali ^{[1
]}

Yerlikaya, Halis ^{[1
]}

Koksoy, Elif B. ^{[1
]}

Karci, Ebru ^{[1
,3
]}

Demirkazik, Ahmet

Akbulut, Hakan

Icli, Fikri

机构：

[1] Ankara Univ, Dept Med Oncol, Sch Med, TR-06590 Ankara, Turkey

[2] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] Ufuk Univ, Dept Med Oncol, Sch Med, TR-06830 Ankara, Turkey

来源：

FUTURE ONCOLOGY | 2018年 / 14卷 / 15期

关键词：

prognosis; resectable breast cancer; vitamin D; 25-HYDROXYVITAMIN D LEVELS; 1,25-DIHYDROXYVITAMIN-D3; CHEMOTHERAPY; TRIAL; CELLS;

D O I：

10.2217/fon-2017-0608

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Aim: There are inconsistent results about the effects of vitamin D level on breast cancer prognosis. We aimed to investigate the effect of vitamin D levels on the prognosis of resectable breast cancer in a patient group with highly different clothing styles. Patients & methods: A total of 186 breast cancer patients were enrolled in the study. Results: Vitamin D level was sufficient, insufficient and deficient in 17.2, 52.2 and 30.6% of patients, respectively. There was a significant relationship between clothing style and serum 25 (OH) D levels. We could not establish any relation between vitamin D level and tumor characteristics or survival. Conclusion: Vitamin D supplementation can be more important than diagnostic serum vitamin D level on prognosis of breast cancer.

引用

页码：1461 / 1467

页数：7

共 26 条

[11] The role of vitamin D in cancer prevention
Garland, CF
Garland, FC
Gorham, ED
Lipkin, M
Newmark, H
Mohr, SB
Holick, MF
[J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2006, 96 (02) : 252 - 261
[12] Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer
Goodwin, Pamela J.
Ennis, Marguerite
Pritchard, Kathleen I.
Koo, Jarley
Hood, Nicky
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (23) : 3757 - 3763
[13] Vitamin D deficiency
Holick, Michael F.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (03) : 266 - 281
[14] Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study
Jacot, W.
Firmin, N.
Roca, L.
Topart, D.
Gallet, S.
Durigova, A.
Mirr, S.
Abach, L.
Pouderoux, S.
D'Hondt, V.
Bleuse, J. P.
Lamy, P. J.
Romieu, G.
[J]. ANNALS OF ONCOLOGY, 2016, 27 (07) : 1235 - 1241
[15] JEMAL A, 2011, CA-CANCER J CLIN, V61, P134, DOI [DOI 10.3322/CAAC.20107, DOI 10.3322/caac.20115]
[16] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS
KAPLAN, EL
MEIER, P
[J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481
[17] Review: The Impacts of Circulating 25-Hydroxyvitamin D Levels on Cancer Patient Outcomes: A Systematic Review and Meta-Analysis
Li, Mian
Chen, Peizhan
Li, Jingquan
Chu, Ruiai
Xie, Dong
Wang, Hui
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (07) : 2327 - 2336
[18] Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer
Lohmann, Ana Elisa
Chapman, Judy-Anne W.
Burnell, Margot J.
Levine, Mark Norman
Tsvetkova, Elena
Pritchard, Kathleen I.
Gelmon, Karen A.
O'Brien, Patti
Han, Lei
Rugo, Hope S.
Albain, Kathy S.
Perez, Edith A.
Vandenberg, Theodore A.
Chalchal, Haji I.
Sawhney, Ravinder Pal Singh
Shepherd, Lois E.
Goodwin, Pamela Jean
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (03) : 605 - 611
[19] Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: Systematic review and meta-analysis of prospective cohort studies
Maalmi, Haifa
Ordonez-Mena, Jose Manuel
Schoettker, Ben
Brenner, Hermann
[J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (08) : 1510 - 1521
[20] MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163

← 1 2 3 →